Randall Moreadith, Chief Scientific Officer at Serina Therapeutics, Inc. (SER), sold 6,500 shares at $3.52 ($23K) on 2025-12-03, disclosed to the SEC on 2025-12-04.
Open-market sale of $23k SER by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.91 | 1,500 | $6K | 25.0% |
| 2 | $3.52 | 5,000 | $18K | 75.0% |
| Total | $3.61 avg | 6,500 | $23K | 100% |
| Filing → |
| SER | SELL | 2026-02-03 | $20K | — | Filing → |
| SER | SELL | 2026-01-29 | $23K | — | Filing → |
| SER | SELL | 2026-01-23 | $7K | — | Filing → |